Malic Acid

Malic Acid

SCHEMBL177314

O=C(O)CC(=O)O.O=C(O)CC(O)C(=O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDRD2HTR1BHTR1DHTR1F

The experimentally established mechanism targets of Malic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.83
LDHA P00338 1/20 0.50
SRR Q9GZT4 1/20 0.50
TET2 Q6N021 6/20 0.48
TET3 O43151 2/20 0.48
TET1 Q8NFU7 1/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
KDM4A O75164 2/20 0.46
KDM4C Q9H3R0 2/20 0.46
KDM2A Q9Y2K7 2/20 0.46
OR51E2 Q9H255 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GABRR1 P24046 2/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malic Acid SCHEMBL14990328 0.97 SMN1; SMN2 (0.79) SMN1; SMN2LDHASRRTET2TET3
Malic Acid SCHEMBL14920139 0.97 SMN1; SMN2 (0.79) SMN1; SMN2LDHASRRTET2TET3
Malic Acid SCHEMBL16783985 0.93 SMN1; SMN2 (0.71) SMN1; SMN2LDHASRRTET2TET3
Malic Acid SCHEMBL31673494 0.91
Malic Acid SCHEMBL856 0.91
Malic Acid SCHEMBL31673489 0.91
Malic Acid SCHEMBL98496 0.91
Malic Acid SCHEMBL14125844 0.91 SMN1; SMN2 (1.00) SMN1; SMN2TET2TET3TET1SLC22A6
Malic Acid SCHEMBL30036864 0.91
Malic Acid SCHEMBL89131 0.91 SMN1; SMN2 (1.00) SMN1; SMN2TET2TET3TET1SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116438295-A Methods and compositions for culturing pluripotent cell suspensions 生命技术公司 2023-07-14 CN disclosed
WO-2021215852-A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION (주)셀트리온 (KR) 2021-10-28 WO disclosed
CN-104540902-B Light polymerization process, ink group, image forming method, ink composite and the Photoepolymerizationinitiater initiater used in them and water-soluble union II imidazoles 富士胶片株式会社 2018-04-24 CN disclosed
CN-105334283-B Simultaneous Determination reconstituted tobacco oxalate, amber acid radical, the sample-pretreating method of sulfate radical and phosphate radical 广东中烟工业有限责任公司 2018-03-27 CN disclosed
CN-105372371-A Ion chromatography method for simultaneous determination of oxalic ion, succinate ion, sulfate ion and phosphate ion in reconstituted tobacco and application thereof CHINA TOBACCO GUANGDONG IND CO 2016-03-02 CN disclosed
CN-105334283-A Sample pretreatment method for simultaneous determination of oxalic acid, succinic acid, sulfuric acid and phosphate radicals in regenerated tobacco leaves through ion chromatography CHINA TOBACCO GUANGDONG IND CO 2016-02-17 CN disclosed
EP-2571837-A1 PROCESSES FOR PRODUCING NH4+ -OOC-R-COOH COMPOUNDS FROM FERMENTATION BROTHS CONTAINING NH4+ -OOC-R-COO-NH4+COMPOUNDS AND/OR HOOC-R-COOH COMPOUND ACIDS, AND CONVERSION OF NH4+ -OOC-R-COOH COMPOUNDS TO HOOC-R-COOH COMPOUND ACIDS Bioamber, S.A.S. (FR) 2013-03-27 EP disclosed
WO-2011136944-A1 PROCESSES FOR PRODUCING NH4 + -OOC-R-COOH COMPOUNDS FROM FERMENTATION BROTHS CONTAINING NH4 + -OOC-R-COO-NH4 +COMPOUNDS AND/OR HOOC-R-COOH COMPOUND ACIDS, AND CONVERSION OF NH4 + -OOC-R-COOH COMPOUNDS TO HOOC-R-COOH COMPOUND ACIDS BIOAMBER S,A.S. (CA) 2011-11-03 WO disclosed
EP-2344487-A1 HEPATITIS C INHIBITOR COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2011-07-20 EP disclosed
EP-2235173-A2 POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME Novozymes A/S (DK) 2010-10-06 EP disclosed
WO-2010034105-A1 HEPATITIS C INHIBITOR COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO disclosed
WO-2009085935-A2 POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME NOVOZYMES A/S (DK) 2009-07-09 WO disclosed